According to the report, HDACs (HDAC1 and HDAC2) are necessary for the growth and survival of RCC tumor cells, and inhibition of HDACs might improve the response of oncologic chemotherapy for RCC (Aggarwal et al., 2017; Kiweler et al., 2018). This evidence concerns the gene HDAC1 and neoplasm.